GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$79.45 USD
+2.05 (2.65%)
Updated Dec 26, 2024 04:00 PM ET
After-Market: $80.10 +0.65 (0.82%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/18/2025
Time: -- |
12/2024 | $0.20 | 0.00% |
Earnings Summary
For their last quarter, GENEDX HOLDINGS (WGS) reported earnings of $0.04 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 121.05%. Look out for WGS's next earnings release expected on February 18, 2025. For the next earning release, we expect the company to report earnings of $0.20 per share, reflecting a year-over-year increase of 133.9%.
Earnings History
Price & Consensus
Zacks News for WGS
Zacks.com featured highlights include Snap, GeneDx and Leonardo
WGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Stocks to Buy for Stellar Earnings Acceleration in November
Best Momentum Stocks to Buy for November 4th
New Strong Buy Stocks for November 4th
WGS FAQs
Based on past history, Zacks believes GeneDx Holdings Corp. (WGS) will report their next quarter earnings on February 18, 2025. For the next earning release, we expect the company to report earnings of 0.20 per share, reflecting a year-over-year increase of 133.90.
Based on past history, Zacks believes GeneDx Holdings Corp. (WGS) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on February 18, 2025.
The Zacks Consensus Estimate for GeneDx Holdings Corp. (WGS) for the quarter ending December 2024 is $0.20 a share. We expect GeneDx Holdings Corp. (WGS) to report earnings in line with the consensus estimate of $0.20 per share
In the earnings report for the quarter ending in September 2024, GeneDx Holdings Corp. (WGS) announced earnings of $0.04 per share versus the Zacks Consensus Estimate of $-0.19 per share, representing a surprise of -121.05%.